Literature DB >> 23797227

Inflammatory myofibroblastic tumor: FDG PET/CT findings with pathologic correlation.

Aisheng Dong1, Yang Wang, Hui Dong, Jing Gong, Chao Cheng, Changjing Zuo, Jianping Lu.   

Abstract

PURPOSE: The aim of this study was to evaluate retrospectively F-FDG PET/CT findings of inflammatory myofibroblastic tumor (IMT) and their correlation with the pathologic findings. PATIENTS AND METHODS: FDG PET/CT findings were reviewed in 5 patients with IMT and 1 patient with spindle cell sarcoma transformed from IMT. PET/CT scans were performed in all 6 patients before surgery. Follow-up FDG PET/CT scan was performed in 1 patient. The location, size, maximal standardized uptake value (SUVmax), and pathologic findings of the tumors were reviewed. The correlation between the FDG uptake and pathologic findings were analyzed.
RESULTS: A total of 10 lesions were detected in all 6 patients. The tumor locations were liver (n = 3), retroperitoneum (n = 2), spleen (n = 1), lung (n = 1), and bone (n = 3). Seven IMTs and 1 spindle cell sarcoma transformed from IMT were confirmed by pathology. The mean SUVmax of the pathologically proven tumors was 10.9 ± 5.5, with a high variability of SUVmax among tumors ranging from 3.3 to 20.8. The tumors (n = 7) with high cellularity had stronger FDG uptake, while the tumors (n = 1) with low cellularity had relatively low FDG uptake. The tumors with nuclear atypia and relatively high proliferative index had very strong FDG uptake, while those with low proliferative index or negative Ki-67 staining had relatively lower FDG uptake. One small tumor with abundant plasma cells showed high FDG uptake, while 1 large tumor with focal inflammatory cell infiltrate showed lower FDG uptake. One patient developed local recurrences and distant metastases revealed by the second FDG PET/CT scan 7 months after resection.
CONCLUSIONS: FDG uptake in IMTs varied from low to high FDG uptake, which may be due to tumor cellularity, biological behaviors of the tumor cells, the composition and the proportion of inflammatory cells, and the extent of activation of the inflammatory cells. FDG PET/CT may be useful for detection of the primary tumors, local recurrences, and distant metastases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23797227     DOI: 10.1097/RLU.0b013e3182952caa

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  15 in total

Review 1.  Shedding light on inflammatory pseudotumor in children: spotlight on inflammatory myofibroblastic tumor.

Authors:  Lillian M Lai; M Beth McCarville; Patricia Kirby; Simon C S Kao; Toshio Moritani; Eve Clark; Kousei Ishigami; Armita Bahrami; Yutaka Sato
Journal:  Pediatr Radiol       Date:  2015-05-12

2.  ROS1-positive Inflammatory Myofibroblastic Tumor of the Small Bowel Causing Obstruction: A Case Report.

Authors:  Anatoly Budylev; Irit Solar; Rivka Kessner; Asaf Aizic
Journal:  J Radiol Case Rep       Date:  2022-01-01

3.  Analysis of clinical features and outcomes for inflammatory myofibroblastic tumors in China: 11 years of experience at a single center.

Authors:  Zuopeng Wang; Xiaolong Zhao; Kai Li; Wei Yao; Kuiran Dong; Xianmin Xiao; Shan Zheng
Journal:  Pediatr Surg Int       Date:  2015-11-21       Impact factor: 1.827

Review 4.  Hepatic inflammatory pseudotumor presenting in an 8-year-old boy: A case report and review of literature.

Authors:  Hussa Al-Hussaini; Haya Azouz; Ahmed Abu-Zaid
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

Review 5.  Assessing the role of ¹⁸F-FDG PET and ¹⁸F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies: a systematic review and meta-analysis.

Authors:  Elba C Etchebehere; Brian P Hobbs; Denái R Milton; Osama Malawi; Shreyaskumar Patel; Robert S Benjamin; Homer A Macapinlac
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-12-03       Impact factor: 9.236

6.  Inflammatory myofibroblastic tumor of the pleura with adjacent chest wall invasion and metastasis to the kidney: a case report.

Authors:  Yong-Sub Na; Sang-Gon Park
Journal:  J Med Case Rep       Date:  2018-09-09

7.  Use of 18F-FDG-PET/CT for Retroperitoneal/Intra-Abdominal Soft Tissue Sarcomas.

Authors:  Dao-Ning Liu; Zhong-Wu Li; Hai-Yue Wang; Min Zhao; Wei Zhao; Chun-Yi Hao
Journal:  Contrast Media Mol Imaging       Date:  2018-07-02       Impact factor: 3.161

8.  Inflammatory Myofibroblastic Tumors in Paranasal Sinus and Nasopharynx: A Clinical Retrospective Study of 13 Cases.

Authors:  Zhenzhen Zhu; Yang Zha; Weiqing Wang; Xiaowei Wang; Yali Gao; Wei Lv
Journal:  Biomed Res Int       Date:  2018-10-15       Impact factor: 3.411

9.  Inflammatory Myofibroblastic Tumor: Findings on 68Ga-DOTA-NOC Positron-emission Tomography-Computed Tomography.

Authors:  Sarthak Tripathy; Mangu Srinivas Bharadwaj; Sreedharan Thankarajan Arun Raj; Sameer Rastogi; Shamim Ahmed Shamim; Sneha Prakash
Journal:  Indian J Nucl Med       Date:  2020-03-12

10.  Kidney inflammatory myofibroblastic tumor masquerading as metastatic malignancy: A case report and literature review.

Authors:  Guo-Hui Zhang; Xiao-Yan Guo; Gao-Zhao Liang; Qing Wang
Journal:  World J Clin Cases       Date:  2019-12-26       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.